Norrin: Molecular and functional properties of an angiogenic and neuroprotective growth factor

Progress in Retinal and Eye Research

Volumn 31, Issue 3, 2012, Pages 243-257

  Ohlmann, Andreas ^a   Tamm, Ernst R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Catenin; Angiogenesis; Glaucoma; M ller cells; Neuroprotection; Retinopathy of prematurity; Wnt

Indexed keywords

BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; FRIZZLED 4 PROTEIN; FRIZZLED 4 RECEPTOR; FRIZZLED PROTEIN; GROWTH FACTOR; LENS EPITHELIUM DERIVED GROWTH FACTOR; N METHYL DEXTRO ASPARTIC ACID; NORRIN; OXYGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN;

ANGIOGENESIS; ANIMAL TISSUE; AUTOCRINE EFFECT; CELL SURVIVAL; COMPLEX FORMATION; EXCITOTOXICITY; EYE DEVELOPMENT; GLAUCOMA; MUELLER CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA GANGLION CELL; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW;

ANIMALS; EYE PROTEINS; FRIZZLED RECEPTORS; GLAUCOMA; HUMANS; INFANT, NEWBORN; MICE; NERVE TISSUE PROTEINS; RETINAL GANGLION CELLS; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84859938636     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.02.002     Document Type: Review

References (90)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 2002, 200:629-638.
2. Alexander J.J., Hauswirth W.W. Adeno-associated viral vectors and the retina. Adv. Exp. Med. Biol. 2008, 613:121-128.
3. Battinelli E.M., Boyd Y., Craig I.W., Breakefield X.O., Chen Z.Y. Characterization and mapping of the mouse NDP (Norrie disease) locus (Ndp). Mamm. Genome 1996, 7:93-97.
4. Benson W.E. Familial exudative vitreoretinopathy. Trans. Am. Ophthalmol. Soc. 1995, 93:473-521.
5. Berger W., van de P.D., Bachner D., Oerlemans F., Winkens H., Hameister H., Wieringa B., Hendriks W., Ropers H.H. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Hum. Mol. Genet. 1996, 5:51-59.
6. Berger W., van de P.D., Warburg M., Gal A., Bleeker-Wagemakers L., de Silva H., Meindl A., Meitinger T., Cremers F., Ropers H.H. Mutations in the candidate gene for Norrie disease. Hum. Mol. Genet. 1992, 1:461-465.
7. Bernstein S.L., Wong P. Regional expression of disease-related genes in human and monkey retina. Mol. Vis. 1998, 4:24.
8. Chen Z.Y., Battinelli E.M., Fielder A., Bundey S., Sims K., Breakefield X.O., Craig I.W. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat. Genet. 1993, 5:180-183.
9. Cuthbertson R.A., Mandel T.E. Anatomy of the mouse retina. Capillary basement membrane thickness. Invest. Ophthalmol. Vis. Sci. 1986, 27:1653-1658.
10. Daneman R., Agalliu D., Zhou L., Kuhnert F., Kuo C.J., Barres B.A. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:641-646.
11. de la Chapelle A., Sankila E.M., Lindlof M., Aula P., Norio R. Norrie disease caused by a gene deletion allowing carrier detection and prenatal diagnosis. Clin. Genet. 1985, 28:317-320.
12. Donnai D., Mountford R.C., Read A.P. Norrie disease resulting from a gene deletion: clinical features and DNA studies. J. Med. Genet. 1988, 25:73-78.
13. Dorrell M.I., Friedlander M. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog. Retin. Eye Res. 2006, 25:277-295.
14. Drenser K.A., Fecko A., Dailey W., Trese M.T. A characteristic phenotypic retinal appearance in Norrie disease. Retina 2007, 27:243-246.
15. Fong G.H. Regulation of angiogenesis by oxygen sensing mechanisms. J. Mol. Med. (Berl) 2009, 87:549-560.
16. Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest. Ophthalmol. Vis. Sci. 2002, 43:522-527.
17. Fujino T., Asaba H., Kang M.J., Ikeda Y., Sone H., Takada S., Kim D.H., Ioka R.X., Ono M., Tomoyori H., Okubo M., Murase T., Kamataki A., Yamamoto J., Magoori K., Takahashi S., Miyamoto Y., Oishi H., Nose M., Okazaki M., Usui S., Imaizumi K., Yanagisawa M., Sakai J., Yamamoto T.T. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:229-234.
18. Gal A., Wieringa B., Smeets D.F., Bleeker-Wagemakers L., Ropers H.H. Submicroscopic interstitial deletion of the X chromosome explains a complex genetic syndrome dominated by Norrie disease. Cytogenet. Cell Genet. 1986, 42:219-224.
19. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M.H., Jackson D., Suri C., Campochiaro P.A., Wiegand S.J., Yancopoulos G.D. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell 2002, 3:411-423.
20. Hackett S.F., Wiegand S., Yancopoulos G., Campochiaro P.A. Angiopoietin-2 plays an important role in retinal angiogenesis. J. Cell. Physiol. 2002, 192:182-187.
21. Hammes H.P., Lin J., Wagner P., Feng Y., Vom Hagen F., Krzizok T., Renner O., Breier G., Brownlee M., Deutsch U. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004, 53:1104-1110.
22. Hartzer M.K., Cheng M., Liu X., Shastry B.S. Localization of the Norrie disease gene mRNA by in situ hybridization. Brain Res. Bull. 1999, 49:355-358.
23. Haseloff R.F., Blasig I.E., Bauer H.C., Bauer H. In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol. Neurobiol. 2005, 25:25-39.
24. He X., Semenov M., Tamai K., Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131:1663-1677.
25. Hendrickx M., Leyns L. Non-conventional Frizzled ligands and Wnt receptors. Dev. Growth Differ. 2008, 50:229-243.
26. Howell G.R., Macalinao D.G., Sousa G.L., Walden M., Soto I., Kneeland S.C., Barbay J.M., King B.L., Marchant J.K., Hibbs M., Stevens B., Barres B.A., Clark A.F., Libby R.T., John S.W. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 2011, 121:1429-1444.
27. -/-) are infertile and exhibit impaired corpora lutea formation and function. Biol. Reprod. 2005, 73:1135-1146.
28. Ito M., Yoshioka M. Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat. Embryol. (Berl.) 1999, 200:403-411.
29. Joly S., Lange C., Thiersch M., Samardzija M., Grimm C. Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J. Neurosci. 2008, 28:13765-13774.
30. Junge H.J., Yang S., Burton J.B., Paes K., Shu X., French D.M., Costa M., Rice D.S., Ye W. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. Cell 2009, 139:299-311.
31. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A., Hartmann C., Li L., Hwang T.H., Brayton C.F., Lang R.A., Karsenty G., Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell. Biol. 2002, 157:303-314.
32. Lenzner S., Prietz S., Feil S., Nuber U.A., Ropers H.H., Berger W. Global gene expression analysis in a mouse model for Norrie disease: late involvement of photoreceptor cells. Invest. Ophthalmol. Vis. Sci. 2002, 43:2825-2833.
33. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., Taketo M.M., von Melchner H., Plate K.H., Gerhardt H., Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008, 183:409-417.
34. Lin S., Cheng M., Dailey W., Drenser K., Chintala S. Norrin attenuates protease-mediated death of transformed retinal ganglion cells. Mol. Vis. 2009, 15:26-37.
35. Lindvall C., Evans N.C., Zylstra C.R., Li Y., Alexander C.M., Williams B.O. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J. Biol. Chem. 2006, 281:35081-35087.
36. Lobov I.B., Rao S., Carroll T.J., Vallance J.E., Ito M., Ondr J.K., Kurup S., Glass D.A., Patel M.S., Shu W., Morrisey E.E., McMahon A.P., Karsenty G., Lang R.A. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005, 437:417-421.
37. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
38. Luhmann U.F., Lin J., Acar N., Lammel S., Feil S., Grimm C., Seeliger M.W., Hammes H.P., Berger W. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest. Ophthalmol. Vis. Sci. 2005, 46:3372-3382.
39. Luhmann U.F., Meunier D., Shi W., Luttges A., Pfarrer C., Fundele R., Berger W. Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis 2005, 42:253-262.
40. Luhmann U.F., Neidhardt J., Kloeckener-Gruissem B., Schafer N.F., Glaus E., Feil S., Berger W. Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled-4. Eur. J. Neurosci. 2008, 27:2619-2628.
41. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
42. Meindl A., Berger W., Meitinger T., van de P.D., Achatz H., Dorner C., Haasemann M., Hellebrand H., Gal A., Cremers F. Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat. Genet. 1992, 2:139-143.
43. Meitinger T., Meindl A., Bork P., Rost B., Sander C., Haasemann M., Murken J. Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat. Genet. 1993, 5:376-380.
44. Nadol J.B., Eavey R.D., Liberfarb R.M., Merchant S.N., Williams R., Climenhager D., Albert D.M. Histopathology of the ears, eyes, and brain in Norrie's disease (oculoacousticocerebral degeneration). Am. J. Otolaryngol. 1990, 11:112-124.
45. Nikopoulos K., Venselaar H., Collin R.W., Riveiro-Alvarez R., Boonstra F.N., Hooymans J.M., Mukhopadhyay A., Shears D., van Bers M., de Wijs I.J., van Essen A.J., Sijmons R.H., Tilanus M.A., van Nouhuys C.E., Ayuso C., Hoefsloot L.H., Cremers F.P. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum. Mutat. 2010, 31:656-666.
46. Norrie G. Causes of blindness in children. Acta Ophthalmol. (Copenh.) 1927, 5:377-386.
47. Ohlmann A., Merkl R., Tamm E.R. Focus on molecules: Norrin. Exp. Eye Res 2011, 10.1016/j.exer.2011.06.016.
48. Ohlmann A., Scholz M., Goldwich A., Chauhan B.K., Hudl K., Ohlmann A.V., Zrenner E., Berger W., Cvekl A., Seeliger M.W., Tamm E.R. Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. J. Neurosci. 2005, 25:1701-1710.
49. Ohlmann A., Seitz R., Braunger B., Seitz D., Bosl M.R., Tamm E.R. Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. J. Neurosci. 2010, 30:183-193.
50. Ohlmann A.V., Adamek E., Ohlmann A., Lutjen-Drecoll E. Norrie gene product is necessary for regression of hyaloid vessels. Invest. Ophthalmol. Vis. Sci. 2004, 45:2384-2390.
51. Paes K.T., Wang E., Henze K., Vogel P., Read R., Suwanichkul A., Kirkpatrick L.L., Potter D., Newhouse M.M., Rice D.S. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest. Ophthalmol. Vis. Sci 2011.
52. Parsons M.A., Curtis D., Blank C.E., Hughes H.N., McCartney A.C. The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age. Graefes Arch. Clin. Exp. Ophthalmol. 1992, 230:248-251.
53. Paxton C.N., Bleyl S.B., Chapman S.C., Schoenwolf G.C. Identification of differentially expressed genes in early inner ear development. Gene Expr. Patterns 2010, 10:31-43.
54. Perez-Vilar J., Hill R.L. Norrie disease protein (norrin) forms disulfide-linked oligomers associated with the extracellular matrix. J. Biol. Chem. 1997, 272:33410-33415.
55. Pfister F., Wang Y., Schreiter K., vom Hagen F., Altvater K., Hoffmann S., Deutsch U., Hammes H.P., Feng Y. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol. 2010, 47:59-64.
56. Phillips C.I., Newton M., Duvall J., Holloway S., Levy A.M. Probably Norrie's disease due to mutation. Two sporadic sibships of two males each, a necropsy of one case, and, given Norrie's disease, a calculation of the gene mutation frequency. Br. J. Ophthalmol. 1986, 70:305-313.
57. Provis J.M. Development of the primate retinal vasculature. Prog. Retin. Eye Res. 2001, 20:799-821.
58. Qin M., Kondo H., Tahira T., Hayashi K. Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. Hum. Genet. 2008, 122:615-623.
59. Rattner A., Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J. Neurosci. 2005, 25:4540-4549.
60. Rehm H.L., Gutierrez-Espeleta G.A., Garcia R., Jimenez G., Khetarpal U., Priest J.M., Sims K.B., Keats B.J., Morton C.C. Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency. Hum. Mutat. 1997, 9:402-408.
61. Rehm H.L., Zhang D.S., Brown M.C., Burgess B., Halpin C., Berger W., Morton C.C., Corey D.P., Chen Z.Y. Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J. Neurosci. 2002, 22:4286-4292.
62. Richter M., Gottanka J., May C.A., Welge-Lussen U., Berger W., Lutjen-Drecoll E. Retinal vasculature changes in Norrie disease mice. Invest. Ophthalmol. Vis. Sci. 1998, 39:2450-2457.
63. Robitaille J., MacDonald M.L., Kaykas A., Sheldahl L.C., Zeisler J., Dube M.P., Zhang L.H., Singaraja R.R., Guernsey D.L., Zheng B., Siebert L.F., Hoskin-Mott A., Trese M.T., Pimstone S.N., Shastry B.S., Moon R.T., Hayden M.R., Goldberg Y.P., Samuels M.E. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 2002, 32:326-330.
64. Ruether K., van de Pol D., Jaissle G., Berger W., Tornow R.P., Zrenner E. Retinoschisislike alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest. Ophthalmol. Vis. Sci. 1997, 38:710-718.
65. Schafer N.F., Luhmann U.F., Feil S., Berger W. Differential gene expression in Ndph-knockout mice in retinal development. Invest. Ophthalmol. Vis. Sci. 2009, 50:906-916.
66. Schroeder B., Hesse L., Bruck W., Gal A. Histopathological and immunohistochemical findings associated with a null mutation in the Norrie disease gene. Ophthalmic Genet. 1997, 18:71-77.
67. Seitz R., Hackl S., Seibuchner T., Tamm E.R., Ohlmann A. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J. Neurosci. 2010, 30:5998-6010.
68. Shastry B.S., Pendergast S.D., Hartzer M.K., Liu X., Trese M.T. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch. Ophthalmol. 1997, 115:651-655.
69. Shastry B.S., Trese M.T. Overproduction and partial purification of the Norrie disease gene product, norrin, from a recombinant baculovirus. Biochem. Biophys. Res. Commun. 2003, 312:229-234.
70. Shen Y., Liu X.L., Yang X.L. N-methyl-D-aspartate receptors in the retina. Mol. Neurobiol. 2006, 34:163-179.
71. Sieving P.A., Caruso R.C., Tao W., Coleman H.R., Thompson D.J., Fullmer K.R., Bush R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3896-3901.
72. Smallwood P.M., Williams J., Xu Q., Leahy D.J., Nathans J. Mutational analysis of Norrin-Frizzled4 recognition. J. Biol. Chem. 2007, 282:4057-4068.
73. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
74. Stenman J.M., Rajagopal J., Carroll T.J., Ishibashi M., McMahon J., McMahon A.P. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 2008, 322:1247-1250.
75. Talcott K.E., Ratnam K., Sundquist S.M., Lucero A.S., Lujan B.J., Tao W., Porco T.C., Roorda A., Duncan J.L. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest. Ophthalmol. Vis. Sci. 2011, 52:2219-2226.
76. Toomes C., Bottomley H.M., Jackson R.M., Towns K.V., Scott S., Mackey D.A., Craig J.E., Jiang L., Yang Z., Trembath R., Woodruff G., Gregory-Evans C.Y., Gregory-Evans K., Parker M.J., Black G.C., Downey L.M., Zhang K., Inglehearn C.F. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am. J. Hum. Genet. 2004, 74:721-730.
77. Wang Y., Huso D., Cahill H., Ryugo D., Nathans J. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. J. Neurosci. 2001, 21:4761-4771.
78. Wang Y., Macke J.P., Abella B.S., Andreasson K., Worley P., Gilbert D.J., Copeland N.G., Jenkins N.A., Nathans J. A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J. Biol. Chem. 1996, 271:4468-4476.
79. Warburg M. Norrie disease: a new hereditary bilateral pseudotumor of the retina. Acta Ophthalmol. 1961, 39:757-772.
80. Warburg M. Norrie disease: atrofia bulborum hereditarum. Acta Ophthalmol. 1963, 41:134-146.
81. Warburg M. Norrie disease: a congenital oculo-acoustico-cerebral degeneration. Acta Ophthalmol. 1966, 89(suppl.):1-147.
82. Warden S.M., Andreoli C.M., Mukai S. The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease. Semin. Ophthalmol 2007, 22:211-217.
83. Xia C.H., Liu H., Cheung D., Wang M., Cheng C., Du X., Chang B., Beutler B., Gong X. A model for familial exudative vitreoretinopathy caused by LPR5 mutations. Hum. Mol. Genet. 2008, 17:1605-1612.
84. Xu Q., Wang Y., Dabdoub A., Smallwood P.M., Williams J., Woods C., Kelley M.W., Jiang L., Tasman W., Zhang K., Nathans J. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004, 116:883-895.
85. Ye X., Smallwood P., Nathans J. Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr. Patterns 2011.
86. Ye X., Wang Y., Cahill H., Yu M., Badea T.C., Smallwood P.M., Peachey N.S., Nathans J. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 2009, 139:285-298.
87. Ye X., Wang Y., Nathans J. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol. Med. 2010, 16:417-425.
88. Young R.W. Cell differentiation in the retina of the mouse. Anat. Rec. 1985, 212:199-205.
89. Young R.W. Cell proliferation during postnatal development of the retina in the mouse. Brain Res. 1985, 353:229-239.
90. Zhang K., Hopkins J.J., Heier J.S., Birch D.G., Halperin L.S., Albini T.A., Brown D.M., Jaffe G.J., Tao W., Williams G.A. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6241-6245.